prednisone has been researched along with tamoxifen in 115 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 53 (46.09) | 18.7374 |
| 1990's | 28 (24.35) | 18.2507 |
| 2000's | 14 (12.17) | 29.6817 |
| 2010's | 18 (15.65) | 24.3611 |
| 2020's | 2 (1.74) | 2.80 |
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Burckhardt, G; Flörl, S; Hagos, Y; Kühne, A; Marada, VV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boesen, E; Derry, CD; Drake, SR; Hanham, IW; Mair, G; McKenzie, C; Senanayake, F; Skeggs, DB; Stoll, BA; Wilson, R | 1 |
| Falkson, CI; Falkson, G; Gelman, RS; Glick, J; Harris, J | 1 |
| Dandapat, MC; Mohapatro, SK; Padhi, NC | 1 |
| Abu-Zahra, H; Arnold, A; Bramwell, V; Findlay, B; Gent, M; Goodyear, MD; Levine, MN; Skillings, J | 1 |
| Luboinski, G; Nagadowska, M; Pienkowski, T | 1 |
| Hartmann, LC; Ingle, JN; Marschke, RF; Schaid, DJ | 1 |
| Bäck, H; Hansson, GK; Nilsson, G; Rödjer, S; Tarkowski, A | 1 |
| Castiglione, M; Gelber, RD; Goldhirsch, A | 2 |
| Dorr, A | 1 |
| Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH | 1 |
| Abu-Zahra, H; Arnold, A; Bramwell, V; DePauw, S; Findlay, B; Gent, M; Hryniuk, WM; Levin, L; Levine, MN; Skillings, J | 1 |
| Camoriano, JK; Ingle, JN; Krook, JE; Loprinzi, CL; Therneau, TM; Veeder, MH | 1 |
| Kennedy, BJ | 1 |
| Fellowes, G; Larsen, W; Rickman, LS | 1 |
| Carbone, PP; Cummings, FJ; Gilchrist, K; Grage, T; Gray, R; Tormey, DC; Woll, JE; Wolter, J | 1 |
| Carbone, PP; Davis, TE; Kline, JC; Love, RR; Palta, M; Tormey, DC | 1 |
| Mouridsen, HT | 1 |
| Cullinan, SA; Everson, LK; Fitzgibbons, RG; Foley, JF; Hagen, JB; Ingle, JN; Krook, JE; Martin, JK; Wieand, HS; Wold, LE | 1 |
| Ahmann, DL; Buckner, JC; Cullinan, SA; Everson, LK; Ingle, JN; Krook, JE; O'Fallon, JR; Pfeifle, DM | 1 |
| Carbone, PP; Cummings, FJ; Falkson, G; Gilchrist, KW; Knuiman, MW; Olson, JE; Rosenthal, SN; Sleeper, LA; Taylor, SG; Tormey, DC | 1 |
| Stewart, HJ | 1 |
| Gelber, RD; Goldhirsch, A | 3 |
| Arafah, BM; Crowe, JP; Gordon, NH; Hubay, CA; Marshall, JS; McGuire, W; Pearson, OH | 1 |
| Cullinan, SA; Everson, LK; Ingle, JN; Krook, JE; Martin, JK; Paulsen, JK; Twito, DI; Votava, HJ; Wieand, HS; Wold, LE | 1 |
| Auclerc, G; Auclerc, M; Baillet, F; Housset, M; Jacquillat, C; Jindani, A; Sellami, M; Soubrane, C; Thill, L; Weil, M | 1 |
| Arnold, A; De Pauw, S; Gent, M; Goodyear, MD; Hirsh, J; Hryniuk, W; Levine, MN | 1 |
| Chang, AY; Davis, TE; Falkson, G; Falkson, HC; Loprinzi, CL; Rasmussen, P; Tormey, DC | 1 |
| Meakin, JW | 2 |
| Cummings, FJ; Gray, R; Knuiman, M; Olson, JE; Taylor, SG; Tormey, DC | 1 |
| Gelman, R; Zelen, M | 1 |
| Gelber, R; Goldhirsch, A | 1 |
| Dillon, HJ; Dnistrian, AM; Fracchia, AA; Greenberg, EJ; Hakes, TB; Schwartz, MK | 1 |
| Bonadonna, G; Brambilla, C; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U; Zambetti, M | 1 |
| Costanzi, JJ; Cruz, T; Fabian, CJ; Foulkes, M; Knight, WA; McDivitt, R; Osborne, CK; Rivkin, SE | 2 |
| Rosso, R; Scarsi, PG; Sertoli, MR | 1 |
| Bennett, JM; Cassileth, PA | 1 |
| Henderson, IC | 1 |
| Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC | 1 |
| Bonadonna, G; Valagussa, P | 1 |
| Fisher, B; Wolmark, N | 1 |
| Bowman, WD; Cullinan, SA; Everson, LK; Green, SJ; Ingle, JN; Krook, JE; Laurie, JA; Marschke, RF; Pfeifle, DM; Windschitl, HE | 1 |
| Goldhirsch, A | 2 |
| Come, SE; Gargan, TJ; Satwicz, PR | 1 |
| Rubens, RD | 1 |
| Alessandroni, M; Silber, JH | 1 |
| Fosså, SD; Gundersen, S; Høst, H; Kvaløy, S | 1 |
| Carbone, PP | 1 |
| Arafah, B; Crowe, JP; Gordon, NH; Guyton, SP; Hubay, CA | 1 |
| Gelber, RD | 1 |
| Gray, R; Olson, JE; Taylor, SG; Tormey, DC | 1 |
| Tormey, C | 1 |
| Bonadonna, G; Brambilla, C; Rossi, A; Valagussa, P | 1 |
| Tormey, DC | 1 |
| Davis, TE; Rose, DP | 1 |
| Alberto, P; Brunner, KW; Cavalli, F; Goldhirsch, A; Jungi, WF; Martz, G; Mermillod, B; Pedrazzini, A | 1 |
| Alberto, P; Brunner, K; Cavalli, F; Jungi, F; Martz, G | 1 |
| Allegra, JC; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
| Heuson, JC; Paridaens, R | 1 |
| Alberto, P; Beer, M; Brunner, KW; Cavalli, F; Jungi, WF; Martz, G; Mermillod, B; Obrecht, JP | 1 |
| Cunningham, T; Dao, TL; Horton, J; Nemoto, T; Rosner, D; Simon, R; Snyderman, M; Sponzo, R | 1 |
| Børmer, O; Fosså, SD; Lund, G; Telhaug, R | 1 |
| Smith, DC; Trump, DL | 1 |
| Castiglione-Gertsch, M; Collins, J; Cortes-Funes, H; Forbes, J; Gelber, RD; Goldhirsch, A; Hacking, A; Johnsen, C; Lindtner, J; Rudenstam, CM | 1 |
| Castiglione, M; Coates, AS; Collins, J; Gelber, RD; Goldhirsch, A; Hacking, A; Lindtner, J; Marini, G; Price, KN; Rudenstam, CM | 1 |
| Abeloff, MD; Costanzi, JJ; Cruz, AB; Farrar, WB; Green, S; Jewell, WR; Metch, B; Minton, JP; Osborne, CK; Rivkin, SE | 1 |
| Miller, WR; Mullen, P | 1 |
| Abeloff, MD; Falkson, G; Falkson, HC; Gilchrist, K; Gray, R; Tormey, DC | 1 |
| Morganroth, ML; Parshley, M; Savelli, BA | 1 |
| Anderson, ED; Anderson, TJ; Cameron, DA; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC; Levack, P | 1 |
| Abeloff, MD; Cummings, FJ; Falkson, G; Gelman, RS; Osborne, CK; Pandya, KJ; Sledge, GW; Tormey, D | 1 |
| Castiglione-Gertsch, M; Coates, A; Collins, J; Gelber, RD; Goldhirsch, A; Gudgeon, A; Hacking, A; Isley, M; Lindtner, J; Rudenstam, CM; Senn, HJ; Tattersall, M | 1 |
| Confalonieri, C; Fossati, R; Ghislandi, E; Liberati, A; Penna, A; Pistotti, V; Tinazzi, A; Torri, V | 1 |
| Byrne, MJ; Castiglione-Gertsch, M; Cortés-Funes, H; Ellis, IO; Elston, CW; Gelber, RD; Goldhirsch, A; Golouh, R; Gusterson, BA; Lindtner, J; Murray, S; Pinder, SE; Rudenstam, CM; Simoncini, E; Trihia, H | 1 |
| Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A | 1 |
| Ajarim, D; Al-Sayed, A; Bazarbashi, S; Berry, J; El-Foudeh, MO; Ezzat, AA; Ibrahim, EM; Rahal, M; Stuart, RK | 1 |
| Sauter, C | 1 |
| Ames, F; Asmar, L; Booser, DJ; Brito, RA; Buzdar, AU; Frye, D; Hortobagyi, GN; Kau, SW; McNeese, M; Ross, M; Singletary, SE; Strom, E; Theriault, RL; Valero, V | 1 |
| Bernardo, MV; Harrington, DP | 1 |
| Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N | 1 |
| Castiglione-Gertsch, M; Coates, AS; Collins, J; Crivellari, D; Fey, MF; Gelber, RD; Goldhirsch, A; Lindtner, J; Price, K; Rudenstam, CM; Senn, HJ | 1 |
| Aebersold, DM; Altermatt, HJ; Berclaz, G; Djonov, V; Greiner, RH; Gruber, G; Hlushchuk, R | 1 |
| Barber, GG; Jetty, P | 1 |
| de Beus, E; Rensma, PL | 1 |
| Chacko, S; Denton, T; Oreopoulos, DG; Rodriguez-Justo, M; Roscoe, J; Sikaneta, T; Stein, J; Tam, P; Taskapan, H; Ting, R; Woods, E | 1 |
| Friedlander, PL; Hasney, CP; Kahn, MJ; Kandil, E; Levy, JM; Occhipinti, EA | 1 |
| Calamia, KT; Hunder, GG; Matteson, EL; Miller, DV; Pipitone, N; Salvarani, C; Warrington, KJ | 1 |
| Tushuizen, ME; Tuynman, HA; van Veen, MC | 1 |
| Alberici, F; Buzio, C; Cobelli, R; Corradi, D; Ferretti, S; Ferrozzi, F; Maggiore, U; Palmisano, A; Salvarani, C; Vaglio, A | 1 |
| Engel, J; Govinda, A; Onitilo, AA | 1 |
| Aguiar Bujanda, D; Hernández Sosa, M | 1 |
| Fagerland, MW; Newcombe, RG | 1 |
| Carbonell, S; Jover, R; Lluís, F; Melgar, P; Payá, A; Romero, M; Vilas, I | 1 |
| Barnes, K | 1 |
| Abanador-Kamper, N; Brandt, AS; Ekamp, H; Haage, P; Kamper, L; Piroth, W; Roth, S | 1 |
| Cho, R; Ghag, D; Karim, MA; Lo, C | 1 |
| Hernández-Calleros, J; Paredes, H; Peláez-Luna, M; Soriano Rios, A; Uscanga-Domínguez, L | 1 |
| Alhaj Moustafa, M; Bi, Y; Brahmbhatt, B; Cortés, P; Daoud, N; Ghoz, HM; Mzaik, O; Pang, M | 1 |
| Han, J; He, H; Li, J; Qiao, J; Si, M; Yao, Y; Zhang, K | 1 |
12 review(s) available for prednisone and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Adjuvant therapy in breast cancer.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Prednisone; Tamoxifen; Vincristine | 1990 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Research Design; Tamoxifen | 1985 |
Adjuvant therapy in primary breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Hospitalization; Humans; Lymph Nodes; Melphalan; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Random Allocation; Tamoxifen; Time Factors; United States; Vincristine | 1985 |
Breast cancer chemotherapy: perioperative considerations in breast reconstruction.
Topics: Adult; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Methotrexate; Middle Aged; Prednisone; Surgery, Plastic; Tamoxifen; Thiotepa; Vincristine | 1985 |
Systemic adjuvant therapy and breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1985 |
Hormone receptors. An update and application.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Prednisone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Vincristine | 1984 |
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 1998 |
Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature.
Topics: Fibrosis; Glucocorticoids; Humans; Hypergammaglobulinemia; Immunoglobulin G; Male; Middle Aged; Prednisone; Renal Insufficiency; Retroperitoneal Fibrosis; Sialadenitis; Tamoxifen | 2009 |
Radiation-induced bronchiolitis obliterans organizing pneumonia.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cryptogenic Organizing Pneumonia; Female; Gamma Rays; Humans; Prednisone; Radiation Injuries; Tamoxifen | 2012 |
[Mesenteric panniculitis of the colon].
Topics: Anti-Bacterial Agents; Biopsy; Colitis, Ischemic; Colonic Diseases; Colonoscopy; Colostomy; Combined Modality Therapy; Escherichia coli Infections; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Male; Meropenem; Mesentery; Middle Aged; Morphine; Panniculitis, Peritoneal; Parenteral Nutrition, Total; Prednisone; Pseudomonas Infections; Tamoxifen; Thienamycins; Travel | 2014 |
Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review.
Topics: Endometrial Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Retroperitoneal Fibrosis; Tamoxifen; Uterine Hemorrhage | 2022 |
60 trial(s) available for prednisone and tamoxifen
| Article | Year |
|---|---|
Adjuvant hormono-chemotherapy in operable breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Tamoxifen | 1978 |
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Tamoxifen; Vincristine | 1992 |
Systemic adjuvant therapy in women with resected node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Receptors, Estrogen; Tamoxifen; Time Factors | 1991 |
Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Evaluation Studies as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Tamoxifen | 1990 |
Adjuvant therapy in breast cancer.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Prednisone; Tamoxifen; Vincristine | 1990 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Survival Analysis; Tamoxifen | 1990 |
A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Randomized Controlled Trials as Topic; Tamoxifen; Vincristine | 1990 |
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Menopause; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Tamoxifen; Weight Gain | 1990 |
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Prevalence; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 1990 |
Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Cause of Death; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Simple; Neoplasm Recurrence, Local; Prednisone; Probability; Randomized Controlled Trials as Topic; Tamoxifen | 1990 |
How to improve adjuvant treatment results in postmenopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Meta-Analysis as Topic; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Tamoxifen; Vincristine | 1989 |
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Staging; Prednisone; Random Allocation; Tamoxifen | 1989 |
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Tamoxifen | 1989 |
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Receptors, Estrogen; Tamoxifen | 1989 |
Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Ovariectomy; Prednisone; Randomized Controlled Trials as Topic; Scotland; Survival Rate; Tamoxifen | 1989 |
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen | 1989 |
Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Mastectomy; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prednisone; Survival Rate; Tamoxifen | 1989 |
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Analysis; Tamoxifen; Vincristine | 1989 |
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy; Menopause; Middle Aged; Postoperative Care; Prednisone; Random Allocation; Tamoxifen | 1988 |
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prednisone; Pulmonary Embolism; Random Allocation; Tamoxifen; Thrombosis; Time Factors; Vincristine | 1988 |
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Clinical Laboratory Techniques; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Methotrexate; Mitolactol; Neoplasm Metastasis; Prednisone; Prognosis; Prospective Studies; Random Allocation; Tamoxifen; Vincristine | 1986 |
Review of Canadian trials of adjuvant endocrine therapy for breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Canada; Clinical Trials as Topic; Female; Humans; Lymph Nodes; Middle Aged; Ovary; Prednisone; Tamoxifen | 1986 |
Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Methotrexate; Middle Aged; Postoperative Period; Prednisone; Receptors, Estrogen; Tamoxifen | 1986 |
Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Prednisone; Receptors, Estrogen; Switzerland; Tamoxifen | 1986 |
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Quality of Life; Statistics as Topic; Tamoxifen | 1986 |
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Nodes; Methotrexate; Prednisone; Random Allocation; Receptors, Estrogen; Tamoxifen; Vincristine | 1985 |
Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1985 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Obesity; Prednisone; Prognosis; Random Allocation; Receptors, Estrogen; Risk; Tamoxifen | 1985 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Research Design; Tamoxifen | 1985 |
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Middle Aged; Prednisone; Random Allocation; Receptors, Estrogen; Tamoxifen; Time Factors | 1985 |
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Nodes; Mastectomy; Methotrexate; Ovariectomy; Prednisone; Random Allocation; Receptors, Estrogen; Tamoxifen; Vincristine | 1985 |
Adjuvant treatment in operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Patient Compliance; Prednisone; Random Allocation; Receptors, Estrogen; Tamoxifen | 1985 |
Breast cancer chemotherapy: perioperative considerations in breast reconstruction.
Topics: Adult; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mastectomy; Melphalan; Methotrexate; Middle Aged; Prednisone; Surgery, Plastic; Tamoxifen; Thiotepa; Vincristine | 1985 |
Systemic adjuvant therapy and breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1985 |
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Tamoxifen | 1984 |
[Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer].
Topics: Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Ovary; Prednisone; Tamoxifen | 1983 |
Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Tamoxifen | 1983 |
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Prednisone; Prognosis; Tamoxifen | 1984 |
Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1984 |
Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Prognosis; Tamoxifen; Vincristine | 1984 |
Review: experience of randomized trials without surgical controls.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1984 |
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Chlorambucil; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Tamoxifen; Vincristine | 1983 |
Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Random Allocation; Tamoxifen; Vincristine | 1980 |
Surgical adjuvant trials in the United States.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prednisone; Random Allocation; Tamoxifen; Vincristine | 1980 |
[Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Estrogen Antagonists; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prednisone; Random Allocation; Tamoxifen; Vincristine | 1982 |
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Tamoxifen; Vincristine | 1982 |
Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Middle Aged; Prednisone; Random Allocation; Recurrence; Tamoxifen | 1982 |
A phase I trial of high-dose oral tamoxifen and CHOPE.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prednisone; Tamoxifen; Vincristine | 1995 |
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Ovariectomy; Postmenopause; Prednisone; Premenopause; Survival Rate; Switzerland; Tamoxifen | 1994 |
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Incidence; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Proportional Hazards Models; Survival Analysis; Tamoxifen; Treatment Outcome | 1994 |
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Prednisone; Proportional Hazards Models; Receptors, Estrogen; Tamoxifen; United States; Vincristine | 1994 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Rate; Tamoxifen; Thiotepa; Vinblastine | 1993 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Goserelin; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Prednisone; Preoperative Care; Tamoxifen; Treatment Outcome; Vincristine | 1997 |
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Survival Rate; Tamoxifen | 1998 |
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Estrogen Antagonists; Female; Fluorouracil; Forecasting; Humans; Lymph Nodes; Mastectomy; Methotrexate; Neoplasm Invasiveness; Postmenopause; Prednisone; Premenopause; Prognosis; Proportional Hazards Models; Survival Rate; Tamoxifen | 1998 |
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine | 2000 |
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Prospective Studies; Radiography; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine | 2001 |
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Follow-Up Studies; Humans; Male; Prednisone; Proportional Hazards Models; Survival Analysis; Tamoxifen; Treatment Outcome | 2003 |
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Remission Induction; Retroperitoneal Fibrosis; Secondary Prevention; Tamoxifen; Young Adult | 2011 |
47 other study(ies) available for prednisone and tamoxifen
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2015 |
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Mitolactol; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen | 1992 |
Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy; Methotrexate; Middle Aged; Nausea; Ovariectomy; Prednisone; Tamoxifen; Thrombophlebitis; Vomiting | 1992 |
Preoperative chemotherapy in primarily inoperable cancer of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Rate; Tamoxifen; Vincristine | 1991 |
M-component with reactivity against actin associated with thrombotic thrombocytopenic purpura.
Topics: Actins; Aged; Aged, 80 and over; Female; Humans; Paraproteinemias; Paraproteins; Prednisone; Purpura, Thrombotic Thrombocytopenic; Tamoxifen | 1991 |
Breast cancer staging and the "alert": an educational dilemma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Communication; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Staging; Prednisone; Publishing; Tamoxifen | 1990 |
Life-threatening hypercalcemia and tamoxifen.
Topics: Aged; Calcitonin; Female; Humans; Hydrocortisone; Hypercalcemia; Megestrol; Megestrol Acetate; Prednisone; Sodium Chloride; Tamoxifen | 1990 |
Short term high density systemic therapy for metastatic breast cancer.
Topics: Altretamine; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Fluoxymesterone; Humans; Leucovorin; Leukopenia; Lung; Methotrexate; Mitolactol; Neoplasm Metastasis; Prednisone; Receptors, Estrogen; Tamoxifen; Thrombocytopenia; Time Factors; Vincristine | 1985 |
Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Breast Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Doxorubicin; Evaluation Studies as Topic; Fluorouracil; Humans; Iridium Radioisotopes; Methotrexate; Prednisone; Radioisotope Teletherapy; Remission Induction; Tamoxifen; Thiotepa; Vinblastine | 1988 |
Assessment of adjuvant trials in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Evaluation Studies as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; International Cooperation; Lymph Nodes; Methotrexate; Middle Aged; Prednisone; Prognosis; Tamoxifen | 1986 |
Chemohormonal therapy and endocrine function in breast cancer patients.
Topics: Adult; Amenorrhea; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estrogens; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Pituitary Hormones; Prednisone; Prolactin; Tamoxifen; Vincristine | 1985 |
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Leukopenia; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Receptors, Estrogen; Retrospective Studies; Tamoxifen | 1985 |
Rationale for combining chemotherapy and hormonal therapy in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Estrogen Antagonists; Female; Fluorouracil; Humans; Interphase; Menopause; Methotrexate; Ovariectomy; Prednisone; Tamoxifen; Vincristine | 1985 |
Effectiveness of acute nonlymphocytic leukemia induction chemotherapy in acute lymphocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia, Lymphoid; Middle Aged; Mitolactol; Prednisone; Tamoxifen; Thioguanine; Time Factors; Vincristine | 1985 |
Chemoendocrine versus endocrine therapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Fluorouracil; Humans; Methotrexate; Prednisone; Receptors, Estrogen; Tamoxifen | 1984 |
Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Topics: Adrenal Cortex; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Ovary; Prednisone; Sex Hormone-Binding Globulin; Tamoxifen | 1980 |
Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Hysterectomy; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
[Hormonal treatment of breast cancer in men. Experiences with antiestrogen Tamoxifen].
Topics: Aged; Breast Neoplasms; Castration; Diethylstilbestrol; Humans; Male; Middle Aged; Prednisone; Tamoxifen | 1982 |
Is there a place for adjuvant endocrine therapy of breast cancer?
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Castration; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Ovary; Prednisone; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen | 1980 |
Factors influencing aromatase activity in the breast.
Topics: Adipose Tissue; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast; Breast Diseases; Breast Neoplasms; Bucladesine; Cells, Cultured; Culture Media, Conditioned; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Hydrocortisone; Kinetics; Prednisone; Tamoxifen; Vincristine | 1993 |
Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen.
Topics: Adult; Anticarcinogenic Agents; Female; Fibrosis; Humans; Mediastinitis; Neck; Prednisone; Sclerosis; Tamoxifen | 1997 |
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome | 1997 |
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bleomycin; Bone Marrow; Cyclophosphamide; Dacarbazine; Danazol; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nimustine; Peptide Fragments; Prednisone; Probability; Procarbazine; Prognosis; Proteinuria; Recurrence; Remission Induction; Reproducibility of Results; Tamoxifen; Time Factors; Vincristine | 1995 |
[Diagnostic problems due to alternative medicine].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Radiography; Skin; Tamoxifen; Vinblastine; Vincristine | 2000 |
Sample size calculations for the two-sample problem using the multiplicative intensity model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Fluoxymesterone; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Likelihood Functions; Markov Chains; Methotrexate; Models, Biological; Prednisone; Randomized Controlled Trials as Topic; Sample Size; Tamoxifen | 2001 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine | 2003 |
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Life Tables; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Paclitaxel; Prednisone; Prognosis; Receptors, Progesterone; Risk; Survival Analysis; Tamoxifen; Taxoids; Transcription Factors; Vincristine | 2004 |
Aortitis and bilateral ureteral obstruction after endovascular repair of abdominal aortic aneurysm.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents; Anticarcinogenic Agents; Aortic Aneurysm, Abdominal; Aortitis; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Humans; Inflammation Mediators; Male; Postoperative Complications; Prednisone; Stents; Tamoxifen; Tomography, X-Ray Computed; Ureteral Obstruction; Vascular Surgical Procedures | 2004 |
[Fatigue, loss of appetite and anuria due to retroperitoneal fibrosis].
Topics: Aged; Anemia; Anti-Inflammatory Agents; Anuria; Diagnosis, Differential; Fatigue; Feeding and Eating Disorders; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Retroperitoneal Fibrosis; Tamoxifen; Treatment Outcome | 2007 |
Combined mycophenolate mofetil and prednisone therapy in tamoxifen- and prednisone-resistant Reidel's thyroiditis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Humans; Mycophenolic Acid; Prednisolone; Prednisone; Tamoxifen; Thyroid Gland; Thyroidectomy; Thyroiditis; Treatment Outcome | 2010 |
Vasculitis of the gastrointestinal tract in chronic periaortitis.
Topics: Administration, Oral; Adult; Aged; Angiography; Biopsy; Disease Progression; Female; Gastrointestinal Tract; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Retroperitoneal Fibrosis; Retrospective Studies; Risk Factors; Tamoxifen; Tomography, X-Ray Computed; Vasculitis | 2011 |
A palpable mass and diarrhea.
Topics: Abdomen; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Diarrhea; Humans; Male; Middle Aged; Palpation; Panniculitis, Peritoneal; Prednisone; Tamoxifen | 2011 |
Radiation-induced bronchiolitis obliterans organizing pneumonia: a case report and literature review.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cryptogenic Organizing Pneumonia; Female; Gamma Rays; Humans; Prednisone; Radiation Injuries; Tamoxifen | 2012 |
Confidence intervals for odds ratio and relative risk based on the inverse hyperbolic sine transformation.
Topics: Confidence Intervals; Data Interpretation, Statistical; Gram-Negative Bacteria; Gram-Positive Bacteria; Human papillomavirus 11; Humans; Leg Ulcer; Odds Ratio; Oropharyngeal Neoplasms; Papillomaviridae; Prednisone; Retroperitoneal Fibrosis; Risk; Tamoxifen | 2013 |
What Is Your Diagnosis? Sclerosing encapsulating peritonitis.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Dog Diseases; Dogs; Female; Peritoneal Fibrosis; Prednisone; Tamoxifen | 2015 |
Diffusion-weighted MRI in the follow-up of chronic periaortitis.
Topics: Anti-Inflammatory Agents; Aorta, Abdominal; Aortitis; Chronic Disease; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisone; Retrospective Studies; Tamoxifen | 2015 |
Encapsulating peritoneal sclerosis: surgery, sustained drug therapy and treatment of recurrence at 1 year.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Nausea; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Fibrosis; Prednisone; Tamoxifen; Tomography, X-Ray Computed; Treatment Outcome; Vomiting | 2015 |
Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease.
Topics: Adult; Age of Onset; Aged; Autoimmune Diseases; Azathioprine; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Male; Middle Aged; Prednisone; Prospective Studies; Retroperitoneal Fibrosis; Retrospective Studies; Steroids; Tamoxifen; Treatment Outcome | 2019 |
Colchicine as an Alternative First-Line Treatment of Sclerosing Mesenteritis: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Colchicine; Humans; Mesentery; Middle Aged; Panniculitis, Peritoneal; Prednisone; Retrospective Studies; Tamoxifen | 2022 |